Status:
COMPLETED
Ranibizumab for Diabetic Traction Retinal Detachment
Lead Sponsor:
University of Sao Paulo
Conditions:
Diabetic Retinopathy
Retinal Detachment
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
The purpose of this study was to assess the effect of ranibizumab in reducing intraoperative vitreous haemorrhage during pars plana vitrectomy, thus facilitating surgery and improving its anatomical a...
Eligibility Criteria
Inclusion
- Macular traction retinal detachment lasting three months or less secondary to diabetic retinopathy.
Exclusion
- Massive vitreous hemorrhage preventing from detailed posterior pole examination;
- Previous intra-ocular surgery other than cataract surgery
- Hemodialysis, known bleeding disorders or use of anticoagulants drugs other than aspirin
- Prothrombin time, partial thromboplastin time or platelet count without normal limits
- History of previous thromboembolic events
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT01201161
Start Date
December 1 2008
End Date
January 1 2010
Last Update
September 14 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of São Paulo
Ribeirão Preto, São Paulo, Brazil, 14048-900